Moderna Stock News

Moderna could have a new vaccine to tackle the Omicron variant in 2022. With mRNA vaccines the pharmaceutical company can move very fast, says its chief medical officer.

Bloomberg Moderna Inc. Chief Medical Officer Paul Burton said he suspects the new omicron coronavirus variant may elude current vaccines, and if so, a reformulated shot could be available early in the new year.We should know about the ability of the current vaccine to provide protection in the next couple of weeks, Burton said

Chief medical officer Paul Burton says mRNA vaccines can be adjusted quickly

A reformulated vaccine could be available early in 2022, Moderna''s chief medical officer Paul Burton said.

Pfizer and Johnson & Johnson said they''re also testing whether their vaccines are effective at fighting the new Omicron variant.

Sumitomo Mitsui DS Asset Management Company Ltd increased its position in shares of Moderna, Inc. (NASDAQ:MRNA) by 18.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,282 shares of the companys stock after buying an additional 3,418 shares during the []

Highlights Omicron has made its way to the UK, Germany, Italy, Israel, Belgium and Hong Kong. WHO has classified the new infection as a variant of concern. Omicron or B.1.1.529 strain was first confirmed from a sample collected on 9 November 2021 and was first reported to WHO on 24 November 2021. The new, more infectious variant, Omicron, has made its way to Europe, Australia after circulation across Southern African countries for most of November. The UK, Germany, Italy, Israel, Belgium and Hong Kong reported the first cases on Saturday, while Australia reported the first confirmed infection on Sunday. The arrival of the new variant has been responded to by prompt investigations by the vaccine makers, including Pfizer, BioNTech, Moderna, Johnson & Johnson and AstraZeneca. Must Read: US markets slip on new covid variant fears The onset of the new infections has led the governments to take strict measures to contain or prevent the virus strain from spreading. The UK has tightened its mask-wearing rules and accelerated its testing of international arrivals.

A new, potentially more contagious variant of the coronavirus is already circulating in Europe. A number of countries have banned the entry of passengers from southern Africa, where the Omicron variant was found, in the past two days. Britain, Germany, Italy and the Czech Republic yesterday identified the first cases of people infected with this variant and announced new measures to control the infection. Fears of the new variant and the potential for it to be more resistant to the protection provided by vaccines are raising concerns that the pandemic and related lockdowns and restrictions may last longer than expected. Nearly two years after the start of the pandemic, which claimed the lives of more than 5 million people globally, countries around the world are on the alert. On Friday, a number of countries banned flights from South Africa and neighboring countries to allow time to assess whether this option is more contagious than the currently dominant Delta option. The Republic of South Africa regretted the closure of the borders of dozens of countries for its citizens and travelers and said that the discovery of the new version of Omicron coronavirus thanks to the work of South African scientists should not be "punished" in this way. "This latest series of travel bans is actually punishing South Africa for its progress in genomic sequencing and its ability to discover new variants more quickly.

Bang Sue Grand Station Vaccination Center announced that from November 26, the center will only offer Pfizer and Moderna jabs as 1st, 2nd and 3rd doses, depending on what is available on the day. Those who insist on receiving the AstraZeneca and Sinovac vaccines must make a request before the appointment day. Teenagers aged 12 []

An outlier in the U.S. pharmaceutical industrys vaccine wars, one which uses a totally different technology than the current gene therapy vaccines sold by Moderna, Pfizer, and Johnson & Johnson, says it will have a vaccine ready for testing and manufacturing ready in the next several weeks, according to reports. Novavax was paraphrased by Reuters []

The new potentially more contagious omicron variant of the coronavirus popped up in more European countries on Saturday, just days after being identified in South Africa, leaving governments around the world scrambling to stop the spread. The U.K. on Saturday tightened its rules on mask-wearing and on testing of international arrivals after finding two cases. New cases were confirmed Saturday in Germany and Italy, with Belgium, Israel and Hong Kong also reporting that the variant has been found in travellers. In the U.S., Dr. Anthony Fauci, the governments top infectious diseases expert, said he would not be surprised if the omicron variant was already in the United States, too. We have not detected it yet, but when you have a virus that is showing this degree of transmissibility it almost invariably is ultimately going to go essentially all over, Fauci said on NBC television. Because of fears that the new variant has the potential to be more resistant to the protection offered by vaccines, there are growing concerns around the world that the pandemic and associated lockdown restrictions will persist for far longer than hoped.